LCN2 and chronic obstructive pulmonary disease: The utility of NGAL has been tested in various clinical situations; its increased levels are reported in patients with kidney and rheumatic diseases, pancreatitis, chronic obstructive pulmonary disease, sepsis, and malignancy [32,33].